EVP R&D, Chief Medical Officer
Wed, Apr 1, 2026
Apr 1
5,000 shares @ $19.34
Increased holdings by +5.60%
Net across this filing: -4.50% (-4,000 shares)
62nd largest trade (out of 157)
Option Exercise
Trade made by an officer
Sale tied to a same-time option exercise
Net holdings across this filing: -4.5% (-4,000 shares)
Insider trade was 45% below market price
Price 18% above 200-day moving average